Quantifying spasticity using a robotic device: the QUASAR study

Not Applicable

• Conditions: Stroke; Stroke - Haemorrhagic; Stroke - Ischaemic

• Registration Number: ACTRN12619001123134
• Lead Sponsor: Melbourne Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-12
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Hemiparesis due to a unilateral single clinical stroke
Spasticity in the elbow flexors
Able to give informed consent

Exclusion Criteria

Co-morbid neurological conditions
Recent <6 months pharmacological treatment for spasticity including botulinum toxin and baclofen
Painful shoulder
Significant upper limb pathology e.g. osteoarthritis
Inability to follow a single-stage command
Presence of contractures in the affected upper limb

Study & Design

• Study Type: Observational
• Study Design: Not specified